Clinical trials
Terminated Immune System Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 2 |
| Amgen | 1 |
| Ariad Pharmaceuticals | 1 |
| CRISPR Therapeutics AG | 1 |
| Eli Lilly and Company | 1 |
| Gilead Sciences | 1 |
| Inmagene LLC | 1 |
| Jasper Therapeutics, Inc. | 1 |
| Myrexis Inc. | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Immune System Diseases | 12 |
| Dermatitis | 3 |
| Dermatitis, Atopic | 3 |
| Eczema | 3 |
| Skin Diseases | 3 |
| Autoimmune Diseases | 2 |
| Connective Tissue Diseases | 2 |
| Immunoproliferative Disorders | 2 |
| Lymphatic Diseases | 2 |
| Lymphoproliferative Disorders | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.